Year: 2025
Type: article
Abstract: particularly in areas with suboptimal vaccine uptake.Given pertussis' high mortality in infants and the known burden of Hibrelated diseases, these results support further investigation into how azithromycin might be integrated into broader child survival strategies.Future research should explore vaccine coverage in these communities, assess the long-term sustainability of pathogen reductions, and determine whether azithromycin influences antibiotic resistance patterns or microbiome composition in treated populations.India, with its diverse healthcare landscape, high burden of respiratory infections, and varying vaccine coverage across states, presents a unique context where findings from this study could hold significant relevance.While mass azithromycin distribution has shown a protective effect against B. pertussis and Hib in Niger, similar challenges exist in many parts of India, particularly in rural and tribal regions where immunization rates remain suboptimal and access to healthcare is limited.Pertussis outbreaks still occur in certain regions despite widespread vaccination efforts, and Hib-related pneumonia and meningitis remain important contributors to childhood morbidity and mortality.Given the evidence that biannual azithromycin administration may reduce these infections, its potential as a supplementary intervention, especially in areas with low vaccine penetration, warrants further exploration in the Indian context.
Source: Pediatric Infectious Disease
Author: Vikram S Kumar
Institution: Subbaiah Medical College
Language: English
Subfield: Microbiology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: diamond
OpenAlex ID: W4408638840
